The mission of the Pancreatic Cancer Research Team (PCRT) is to organize and accelerate the clinical development of new agents for the treatment of patients with pancreatic cancer. PCRT is an international collaborative organization formed by several world renowned institutions and researchers. PCRT conducts clinical trials for patients with pancreatic cancer, using innovative genomics research strategies to develop new prevention, diagnostic and treatment methods for patients with pancreatic cancer.
Please visit our PCRT website for more information. We serve the patients, industry, and clinicians.
Find a Clinical Trial Near You
The PCRT network provides the pharmaceutical industry with unrivaled access to a worldwide network of clinical experts in pancreatic cancer.
The PCRT is a collaborative group of physicians with a mission to organize and accelerate the clinical development of new ways to treat pancreatic cancer.
Berg is partnered with PCRT for Project SurvivalTM and for investigation of a new drug to treat pancreatic cancer. The Translational Genomics Research Institute (TGen) provides support for some PCRT pancreatic cancer clinical trials.